InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.21
(
0.10%
)
Bitcoin
64,239.10
(
0.38%
)
Post# of 64575
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

deri21

Send PM Follow Ignore
Followers 51
Posts 9693
Boards Moderated 0
Alias Born 06/06/2009

deri21

Re: None

Thursday, 04/04/2024 10:08:48 AM

Thursday, April 04, 2024 10:08:48 AM

Post# of 64575
$HALB Halberd Corporation's (OTC PINK:HALB) Patented LDN+ Drug hits an enormous milestone as it enters a significant Safety Trial Protocol under a CRADA contract for Military Active Duty and Veterans.
https://www.accesswire.com/849919/halberds-patented-drug-ldn-the-subject-of-a-limited-clinical-trial-under-an-innovative-four-company-cooperative-research-and-development-crada-contract
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up